NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Ingevity Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$70.31+0.49 (+0.70%)
Close on Oct 19, 2026
- Market cap
- $2.48B
- P/E (TTM)
- 47.8
- Dividend yield
- –
Share price
+$15.99 (+29.44%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Ingevity Corp saw revenue fall 1.4% to $1.16B over the twelve months to Jun 30, 2026. Operating income fell 1.7% to $418.70M, moving the operating margin from 36.2% to 36.1%. Free cash flow was $154.90M, up 3.1% from a year earlier.
Revenue
$1.16B
-1.4% vs. a year earlier
Operating income
$418.70M
-1.7% vs. a year earlier
Free cash flow
$154.90M
+3.1% vs. a year earlier
EPS, diluted
$1.47
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.48B
- P/E ratio
- 47.8
- Price to sales
- 2.14
- Price to book
- 52.89
- Dividend yield
- –
- Free cash flow yield
- 6.24%
Fundamentals
- Revenue
- $1.16B
- Net income
- $54.00M
- EPS, diluted
- $1.47
- Free cash flow
- $154.90M
- Book value per share
- $1.33
- Diluted shares
- 35M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$1.16B-1.4% YoY
Gross profit
$477.10M+1.3% YoY
Operating income
–
Net income
$54.00M
EPS, diluted
$1.47
Free cash flow
$154.90M+3.1% YoY
Reported periodTrailing twelve months